474 Results (Page 11 of 19)
Egypt Markets Research Reports
Egypt Ophthalmic Drugs Market Analysis
Egypt ophthalmic drugs market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 – 2030. The key factors driving the growth of the global ophthalmic drugs market are the rise in the elderly population, the prevalence of eye diseases like glaucoma, cataracts, and macular degeneration, the surge in ophthalmic drug demand, and the increase in investment in R&D activities by different healthcare companies. The major key players in this market are Pfizer Inc., Alcon, Novartis AG, Bausch Health Companies Inc., Merck & Co., Inc., Regeneron Pharmaceuticals Inc., Allergan (AbbVie Inc.), Bayer AG, Genentech, Inc. (F. Hoffmann-La Roche Ltd), Nicox, Coherus Biosciences, Inc.
Egypt Opioid Drugs Market Analysis
Egypt opioid drugs market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 – 2030. The opioid industry is anticipated to rise as a result of expanding painkiller care facilities, altered prescription laws, and intense generic manufacturers' attention on Abuse-Deterrent Formulation (ADF). The major players in this market are Eva Pharmaceuticals Inc., Mallinckrodt Pharmaceuticals, Amneal Pharmaceuticals Inc., Hikma Pharmaceuticals PLC, and Purdue Pharmaceuticals L.P.
Egypt Opioid Pain Management Market Analysis
Egypt opioid pain management market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Some of the main factors influencing the market's growth include an increase in the use of these painkillers and an increase in the proportion of the elderly population that is particularly susceptible to orthopaedic pain. Additionally, there has been a significant increase in the number of people worldwide who experience chronic pain. The major key players in this market are Pfizer, Inc., Sanofi S.A., Mylan N.V., Teva Pharmaceutical Industries Ltd., etc.
Egypt Opioid Use Disorder Market Analysis
Egypt opioid use disorder market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. The market for opioid use disorders is anticipated to expand in the upcoming years as a result of factors such as an expansion of the patient base and the anticipated introduction of cutting-edge therapies by top firms like Braeburn Pharmaceuticals, BioXcel Therapeutics, MediciNova, AstraZeneca, and others. Some of the major key players in this market are AstraZeneca Plc., BioDelivery Sciences International Inc., Braeburn, Cerebral, Hikma Pharmaceuticals Plc., etc.
Egypt Optogenetics Market Analysis
Egypt optogenetics market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. The rise in the prevalence of neurological illnesses, the rise in optogenetics R&D activities, and the rise in demand for neuroscience research are all contributing factors to the expansion of the optogenetics market. Some of the major key players in this market are Cobalt, Coherent Inc., Gensight Biologics, Laserglow Technologies, Noldus Information Technology, etc.
Egypt Oral Anti-Diabetes Drugs Market Analysis
Egypt oral anti-diabetes drugs market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Due to the rise in type 2 diabetes incidence, the market for oral antidiabetic medications is anticipated to have a considerable increase over the forecast period. The adoption of a bad lifestyle, environmental pollution, and a family history of diabetes disease all contribute to the market growth for oral antidiabetic medications. Some of the major key players in this market are Pfizer Inc., F. Hoffmann-La Roche Ltd., Mylan N.V., Fresenius Kabi AG, etc.
Egypt Oral Contraceptives Market Analysis
Egypt oral contraceptives market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Growth drivers for the market are raising awareness of the advantages of oral contraceptives, increasing the proportion of women working, increasing the number of sexually transmitted diseases (STIs), increasing the usage of reversible long-acting contraception (LARCs), Increasing the number of internet pharmacies. Some of the major key players in this market are Allergan plc, Bayer AG, Johnson & Johnson Services, Inc., Mankind Pharma Ltd., etc.
Egypt Oral Thin Films Market Analysis
Egypt oral thin films market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Oral thin films market size is being driven by an increase in R&D spending on quickly dissolving oral films and a rise in demand for thin-film drug delivery systems. The capacity of Oral Thin Films (OTFs) to include even poorly soluble medications has led to a significant demand for them. The major key players in this market are MonoSol Rx, Tesa Labtec GmbH, Pfizer, Inc., Novartis AG, and Wolters Kluwer.
Egypt Osteoarthritis Drugs Market Analysis
Egypt osteoarthritis drugs market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Increased prevalence of osteoarthritis, improvements in drug development R&D, increased funding from private and public organisations for the development of the healthcare sector and research centres, and increased demand for cell-based research activities are the main factors driving the growth of the osteoarthritis drugs market. Some of the major key players in this market are Pfizer Inc., Abbvie Inc., Novartis AG, Amgen Inc., Boehringer Ingelheim International GmbH, etc.
Egypt Asthma and COPD Therapeutics Market Analysis
The Egypt Asthma and COPD Therapeutics Market was valued at US $94 Mn in 2022, and is predicted to grow at (CAGR) of 6.70% from 2023 to 2030, to US $157 Mn by 2030. The key drivers of this industry include the surge in the prevalence of COPD and asthma, supportive government initiatives, technological advancements, and others. The industry is primarily dominated by players such as Abbott, Pharco, AstraZeneca, Edita, Novartis, ACPICO, and GSK, among others.
Egypt Antibacterial (Antibiotics) Drugs Market Analysis
Egypt Antibacterial (Antibiotics) Drugs Market is at around $0.14 Bn in 2023 and is projected to reach $0.21 Bn in 2030, exhibiting a CAGR of 5.7% during the forecast period. Governmental initiatives and regulations, the prevalence of infectious diseases, and rising healthcare spending are some of the factors driving the market. The market is dominated by key players like Eva Pharma, Pfizer Inc., AbbVie (Allergan), Roche, Novartis AG, GlaxoSmithKline plc, Abbott Laboratories, Johnson & Johnson, Merck & Co., Inc., and Sanofi S.A.
Egypt Anemia Therapeutics Market Analysis
The Egypt Anemia Therapeutics Market is anticipated to experience a growth from $41 Mn in 2022 to $93 Mn by 2030, with a CAGR of 10.6% during the forecast period of 2022-2030. The key drivers for the growth of the Egypt Anemia Therapeutics Market include continuous advancements in pharmaceuticals for enhanced treatment options, a high prevalence of anemia types, particularly IDA, thalassemia, and SCA, necessitating diverse and specific therapies, and growing government initiatives focused on improving healthcare accessibility. The Egypt Anemia Therapeutics Market encompasses various players across different segments, including Novartis, Pfizer, Sanofi, Abbott Laboratories, Teva Pharmaceuticals, Foresee Pharmaceuticals, Jasper Therapeutics, Amoun Pharmaceutical Company, Pharco Pharmaceuticals, Hikma Pharmaceuticals, etc, among various others.
Egypt Dermatological Therapeutics Market Analysis
Egypt Dermatological Therapeutics Market is at around $0.12 Bn in 2023 and is projected to reach $0.23 Bn in 2030, exhibiting a CAGR of 10.10% during the forecast period. The factors driving the expansion of the market are rising awareness, the prevalence of skin disorders, and advancements in treatment technologies. The market is dominated by key players like Egyptian International Pharmaceutical Co. (EPICO), Almirall SA, Pfizer Inc., GlaxoSmithKline Plc, AbbVie Inc., Amgen Inc., Novartis AG, Roche, Sanofi, Bayer, and Johnson & Johnson.
Egypt Digital Therapeutics Market Analysis
Egypt Digital Therapeutics Market is at around $17 Mn in 2023 and is projected to reach $99.43 Mn in 2030, exhibiting a CAGR of 28.7 % during the forecast period. The development of healthcare infrastructure, provider acceptance, and partnerships and collaborations are driving market expansion. The market is dominated by key players like Omada Health Inc., DarioHealth Corp., 2Morrow Inc., Livongo Health Inc., WellDoc, Propeller Health, Canary Health, Noom Inc., Akili Interactive Labs Inc., and Hygieia.
Egypt Alopecia (Hair Loss) Therapeutics Market Analysis
The Egypt Alopecia (Hair Loss) Therapeutics Market was valued at US $23 Mn in 2022, and is predicted to grow at (CAGR) of 9% from 2023 to 2030, to US $46 Mn by 2030. The main drivers advancing this industry are primarily the significant rise in the prevalence of alopecia (hair loss), improved socioeconomic conditions, and others. The industry is primarily dominated by players such as Sun Pharmaceuticals, Johnson & Johnson, Cirrus, Cipla, Lexington, and Merck, among others.
Egypt Allergy Therapeutics Market Analysis
Egypt Allergy Therapeutics Market was valued at $65 Mn in 2022 and is estimated to reach $119 Mn in 2030, exhibiting a CAGR of 7.9% during the forecast period. The need for allergy treatment medications is rising due to the frequency of allergic illnesses and related health issues. The top pharmaceutical companies that are currently operating in the market are Novartis, Sanofi, Johnson & Johnson, GlaxoSmithKline, Pfizer, Merck & Co., Bayer, AstraZeneca, Roche and Teva Pharmaceutical Industries.
Egypt Alcohol Addiction Therapeutics Market Analysis
The Egypt Alcohol Addiction Therapeutics Market is valued at around $2 Mn in 2022 and is projected to reach $4 Mn by 2030, exhibiting a CAGR of 7.8% during the forecast period. The market growth in the country is fueled by the changing societal attitudes, increased middle-class discretionary incomes and the increased government’s efforts to improve healthcare facilities. The key players involved in the research, development, and distribution of Alcohol Addiction Therapeutics in Egypt are Alkermes, Teva Pharmaceuticals, Addex Therapeutics, Opiant Pharmaceuticals, GlaxoSmithKline (GSK), Merck & Co., Pharos Holding, Egypharm, Amoun Pharmaceuticals, Egyptian International Pharmaceutical Marketing Co. (EIPMCO) etc among others.
Egypt Cardiovascular Drugs Market Analysis
Egypt Cardiovascular Drug Market is at around $0.4 Bn in 2022 and is projected to reach $0.6 Bn in 2030, exhibiting a CAGR of 5.3% during the forecast period. The market is expanding as a result of government initiatives, increased access to health insurance, and a rise in cardiovascular load. The market is dominated by key players like Copad Pharma, Menarini Pharmaceutical, Boehringer Ingelheim International GmbH, Bristol-Myers Squibb Co., F. Hoffman-La Roche, Pfizer Inc., Astra Zeneca, Sanofi, Novartis, and GSK.
Egypt Acute Lymphocytic Leukemia (ALL) Therapeutics Market Analysis
The Egypt Acute Lymphocytic Leukemia (ALL) Therapeutics Market was valued at US $9 Mn in 2022, and is predicted to grow at (CAGR) of 9.3% from 2023 to 2030, to US $19 Mn by 2030. The key drivers of this industry include a surge in the incidence of acute lymphocytic Leukemia cases, expanding healthcare infrastructure by continuous investment, increased government funding initiatives and other factors. The industry is primarily dominated by players such as Pharco, EIPICO, Amoun, Novartis, among other players.
Egypt Autosomal Dominant Polycystic Kidney Disease Therapeutics Market Analysis
The Egypt Autosomal Dominant Polycystic Kidney Disease Therapeutics Market was valued at US$3 Mn in 2022, and is predicted to grow at a CAGR of 7.3% from 2023 to 2030, to US$5 Mn by 2030. The key drivers of this industry include the upward trend in the prevalence of autosomal dominant polycystic kidney disease, healthcare infrastructure growth, and other factors. The industry is primarily dominated by players such as Otsuka Pharmaceuticals, AceLink, Palladio, Reata, Xortx, Regulus, Exelixis, Sanofi, and other players.
Egypt Age-Related Macular Degeneration Therapeutics Market Analysis
The Egypt Age-Related Macular Degeneration (AMD) Therapeutics Market was valued at US $30 Mn in 2022 and is predicted to grow at a CAGR of 10.40% from 2023 to 2030, to US $67 Mn by 2030. The key drivers of this industry include the upward trend in the prevalence of age-related macular degeneration, a strong product pipeline, and other factors. The industry is primarily dominated by players such as Novartis, Bayer, Roche, Regeneron Pharmaceuticals, and Genetech, among others
Egypt Addiction Therapeutics Market Analysis
Egypt addiction therapeutics market was valued at $28 Mn in 2022 and is estimated to reach $54 Mn in 2030, exhibiting a CAGR of 8.4% during the forecast period. The industry for addiction treatment is expanding as a result of public awareness raised by anti-drug campaigns and supportive government initiatives. Dominant key players operating in the market include Indivior, Alkermes, Reckitt Benckiser, Otsuka Pharmaceutical Co., Pfizer, Mallinckrodt, Purdue Pharma L.P., GlaxoSmithKline, Teva Pharmaceutical and Novartis
Egypt Actinic Keratosis Therapeutic Market Analysis
Egypt actinic keratosis therapeutics market was valued at $19 Mn in 2023 and is expected to reach $31 Mn by 2030, growing at a CAGR of 6.4%. Factors like high UV radiation exposure in the subtropical climate, an aging population more prone to AK, raising public awareness through media and healthcare initiatives, and easier access to dermatological services are driving the growth of the Egypt Actinic Keratosis Therapeutic Market. Major pharmaceutical companies include Biofrontera, LEO Pharma, 3M, Bausch Health, Novartis, GlaxoSmithKline, Almirall, etc
Egypt eHealth Market Analysis
This report presents a strategic analysis of the Egypt eHealth Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges, and future outlook. This is one of the most comprehensive reports about the Egypt eHealth Market, offering unmatched value, accuracy, and expert insights.
Egypt Radiotherapy Market Analysis
By 2030, it is anticipated that the Egypt Radiotherapy Market will reach a value of $35 Mn from $19 Mn in 2022, growing at a CAGR of 7.5% during 2022-30. The Radiotherapy Therapeutics Market in Egypt is dominated by a few domestic players such as Accuray, Elekta, and Siemens Healthineers. The radiotherapy market in Egypt is segmented into different types, technologies, procedures, applications, and end-users. The major risk factors associated with awareness of radiotherapy shortage of skilled staff, government initiatives, and reimbursement policy. The demand for Egypt Radiotherapy is increasing on account of the rise in cancer cases in the country.